These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8616803)

  • 21. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of transferrin receptor on transitional cell cancer].
    Tomita Y; Nishiyama T; Sato S; Fujiwara M
    Hinyokika Kiyo; 1991 Jan; 37(1):11-6. PubMed ID: 2011963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].
    Moll R; Laufer J; Wu XR; Sun TT
    Verh Dtsch Ges Pathol; 1993; 77():260-5. PubMed ID: 7511294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ.
    Bindels EM; Vermey M; van den Beemd R; Dinjens WN; Van Der Kwast TH
    Cancer Res; 2000 Jan; 60(1):177-83. PubMed ID: 10646871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Simultaneous bilateral renal pelvic tumors: a case report].
    Kanai S; Takagi Y; Tanaka J; Miyake K
    Hinyokika Kiyo; 1991 Dec; 37(12):1703-5. PubMed ID: 1785396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverted papilloma of renal pelvis associated with contralateral ureteral malignancy and bladder recurrence.
    Schultz RE; Boyle DE
    J Urol; 1988 Jan; 139(1):111-3. PubMed ID: 3275792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
    Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression.
    Chopin D; Barei-Moniri R; Maillé P; Le Frère-Belda MA; Muscatelli-Groux B; Merendino N; Lecerf L; Stoppacciaro A; Velotti F
    Am J Pathol; 2003 Apr; 162(4):1139-49. PubMed ID: 12651606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma].
    Li YJ; Zheng BZ; Zhou ZL
    Ai Zheng; 2004 Jun; 23(6):704-6. PubMed ID: 15191676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma.
    Shimazui T; Oosterwijk-Wakka J; Akaza H; Bringuier PP; Ruijter E; Debruyne FM; Schalken JA; Oosterwijk E
    Eur Urol; 2000 Sep; 38(3):331-8. PubMed ID: 10940709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complexity, retinoid-responsive gene networks, and bladder carcinogenesis.
    Hurst RE; Waliszewski P; Waliszewska M; Bonner RB; Benbrook DM; Dar A; Hemstreet GP
    Adv Exp Med Biol; 1999; 462():449-67. PubMed ID: 10599447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.
    Ross JS; Cheung C; Sheehan C; del Rosario AD; Bui HX; Fisher HA
    Diagn Cytopathol; 1996 Jun; 14(4):310-5. PubMed ID: 8725130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
    Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological characteristics of inverted papilloma of the urinary bladder.
    Urakami S; Igawa M; Shirakawa H; Shiina H; Ishibe T
    Br J Urol; 1996 Jan; 77(1):55-60. PubMed ID: 8653317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A clinical survey of renal pelvic and ureteral tumors associated with bladder tumor].
    Matsuki H; Ozono S; Tani Y; Kurooka K; Tsujimoto S; Fujimoto K; Momose H; Kaneko Y; Yoshida K; Okamoto S
    Hinyokika Kiyo; 1989 Feb; 35(2):239-46. PubMed ID: 2735234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
    Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
    J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinosarcoma of urothelial organs: sequential involvement of urinary bladder, ureter, and renal pelvis.
    Orsatti G; Corgan FJ; Goldberg SA
    Urology; 1993 Mar; 41(3):289-91. PubMed ID: 8442318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.